Dates not reported
Sourced institutional rolesLDA lobbying records
MICHAEL TONGOUR
MICHAEL TONGOUR appears as a registered lobbyist in federal Lobbying Disclosure Act records connected to organizations tracked by Paper Trail.
Data updated Aug 31, 2026
Source-backed chronology
Career Timeline
Federal LDA filings
Lobbying Activity
CENCORA, INC.1st Quarter (Jan 1 - Mar 31) 2026
Registrant: TCH GROUP, LLC · Health Issues
Issues related to the pharmaceutical supply chain, drug shortages, drug pricing, national stockpiles, pharmacists' services, and proposals regarding bona fide service fees (2026 Physician Fee Schedule)
LDA filing ↗CENCORA, INC.1st Quarter (Jan 1 - Mar 31) 2017
Registrant: TCH GROUP, LLC · Medicare/Medicaid
Issues relating to the payment of prescription drugs under Medicare Part B Monitoring the American Health Care Act of 2017, HR 1628
LDA filing ↗CENCORA, INC.2nd Quarter (Apr 1 - June 30) 2026
Registrant: TCH GROUP, LLC · Health Issues
Issues related to the pharmaceutical supply chain, drug shortages, drug pricing, national stockpiles, pharmacists' services, and proposals regarding bona fide service fees (2026 Physician Fee Schedule)
LDA filing ↗CENCORA, INC.2nd Quarter (Apr 1 - June 30) 2017
Registrant: TCH GROUP, LLC · Taxation/Internal Revenue Code
Tax reform initiatives
LDA filing ↗CENCORA, INC.1st Quarter (Jan 1 - Mar 31) 2022
Registrant: TCH GROUP, LLC · Health Issues
Issues pertaining to pharmacists' services including S 1362, Pharmacy and Medically Underserved Areas Enhancement Act and HR 7213, Equitable Community Access to Pharmacists Services Issues relating to the pharmaceutical supply chain, stockpiling, and COVID vaccine distribution/drug shortage including HR 2870, Essential Medicines Strategic Stockpile Act Drug pricing legislation, including S 1388
LDA filing ↗CENCORA, INC.4th Quarter (Oct 1 - Dec 31) 2017
Registrant: TCH GROUP, LLC · Health Issues
Legislative initiatives to modify or repeal PL 114-145, Ensuring Patient Access and Effective Drug Enforcement Act of 2016
LDA filing ↗CENCORA, INC.2nd Quarter (Apr 1 - June 30) 2016
Registrant: TCH GROUP, LLC · Pharmacy
S.483, Ensuring Patient Access and Effective Drug Enforcement Act of 2015
LDA filing ↗CENCORA, INC.3rd Quarter (July 1 - Sep 30) 2017
Registrant: TCH GROUP, LLC · Medicare/Medicaid
Issues relating to the payment of prescription drugs under Medicare Part B
LDA filing ↗CENCORA, INC.2nd Quarter (Apr 1 - June 30) 2019
Registrant: TCH GROUP, LLC · Health Issues
Issues concerning Medicare Part D and drug rebate reform
LDA filing ↗CENCORA, INC.3rd Quarter (July 1 - Sep 30) 2017
Registrant: TCH GROUP, LLC · Health Issues
Monitoring efforts to repeal/replace the Affordable Care Act Monitoring policy initiatives pertaining to the opioid crisis
LDA filing ↗CENCORA, INC.4th Quarter (Oct 1 - Dec 31) 2019
Registrant: TCH GROUP, LLC · Health Issues
S 2543 and issues concerning Medicare Part D, drug rebate reform, Medicare Average Sales Price Methodology
LDA filing ↗CENCORA, INC.4th Quarter (Oct 1 - Dec 31) 2017
Registrant: TCH GROUP, LLC · Medicare/Medicaid
Issues relating to the payment of prescription drugs under Medicare Part B
LDA filing ↗CENCORA, INC.4th Quarter (Oct 1 - Dec 31) 2016
Registrant: TCH GROUP, LLC · Medicare/Medicaid
Issues relating to payment of prescription drugs under Medicare Part B HR 592, Pharmacy and Medically Underserved Areas Enhancement Act
LDA filing ↗CENCORA, INC.3rd Quarter (July 1 - Sep 30) 2015
Registrant: TCH GROUP, LLC · Pharmacy
S.483, Ensuring Patient Access and Effective Drug Enforcement Act of 2015
LDA filing ↗CENCORA, INC.1st Quarter (Jan 1 - Mar 31) 2016
Registrant: TCH GROUP, LLC · Pharmacy
S.483, Ensuring Patient Access and Effective Drug Enforcement Act of 2015
LDA filing ↗CENCORA, INC.4th Quarter (Oct 1 - Dec 31) 2018
Registrant: TCH GROUP, LLC · Health Issues
Legislation to improve systems for identifying diversion of controlled substances and for improved reporting of information on the distribution of opioids ( S 2837 and S 2838) Legislative initiatives to modify or repeal PL 114-145, Ensuring Patient Access and Effective Drug Enforcement Act of 2016, ie S 1960 and S 2561 Issues pertaining to pharmaceutical compounding
LDA filing ↗CENCORA, INC.4th Quarter (Oct 1 - Dec 31) 2020
Registrant: TCH GROUP, LLC · Health Issues
Legislative responses to COVID-19 (HR 133), including issues pertaining to vaccine distribution and establishing an emergency pharmacist Medicare provider status in relation to the pandemic
LDA filing ↗CENCORA, INC.3rd Quarter (July 1 - Sep 30) 2018
Registrant: TCH GROUP, LLC · Health Issues
Legislation to improve systems for identifying diversion of controlled substances and for improved reporting of information on the distribution of opioids ( S 2837 and S 2838) Legislative initiatives to modify or repeal PL 114-145, Ensuring Patient Access and Effective Drug Enforcement Act of 2016, ie S 1960 and S 2561 Issues pertaining to pharmaceutical compounding Monitoring HR 6, opioid legislation
LDA filing ↗CENCORA, INC.4th Quarter (Oct 1 - Dec 31) 2021
Registrant: TCH GROUP, LLC · Health Issues
S 1362, Pharmacy and Medically Underserved Areas Enhancement Act S 1909/HR 3554- Pharmacy DIR reform Drug pricing legislation, including S 1388 and provisions in the Build Back Better Act (HR 5376)
LDA filing ↗CENCORA, INC.2nd Quarter (Apr 1 - June 30) 2025
Registrant: TCH GROUP, LLC · Health Issues
Issues related to the pharmaceutical supply chain, drug shortages, drug pricing, national stockpiles, and pharmacists' services
LDA filing ↗CENCORA, INC.2nd Quarter (Apr 1 - June 30) 2020
Registrant: TCH GROUP, LLC · Health Issues
Legislative responses to COVID-19, including issues pertaining to PPP funding, and supplies of pharmaceuticals and PPE
LDA filing ↗CENCORA, INC.1st Quarter (Jan 1 - Mar 31) 2018
Registrant: TCH GROUP, LLC · Medicare/Medicaid
Issues relating to the payment of prescription drugs under Medicare Part B
LDA filing ↗CENCORA, INC.1st Quarter (Jan 1 - Mar 31) 2019
Registrant: TCH GROUP, LLC · Health Issues
Issues concerning Medicare Part D and drug rebate reform
LDA filing ↗CENCORA, INC.1st Quarter (Jan 1 - Mar 31) 2021
Registrant: TCH GROUP, LLC · Health Issues
HR 1319, American Rescue Plan (PL 117-2)- COVID relief including issues pertaining to vaccine distribution.
LDA filing ↗CENCORA, INC.2nd Quarter (Apr 1 - June 30) 2017
Registrant: TCH GROUP, LLC · Medicare/Medicaid
Issues relating to the payment of prescription drugs under Medicare Part B Monitoring the American Health Care Act of 2017, HR 1628
LDA filing ↗CENCORA, INC.1st Quarter (Jan 1 - Mar 31) 2018
Registrant: TCH GROUP, LLC · Health Issues
Legislative initiatives to modify or repeal PL 114-145, Ensuring Patient Access and Effective Drug Enforcement Act of 2016, ie S 1960 and S 2561 Issues pertaining to pharmaceutical compounding
LDA filing ↗CENCORA, INC.3rd Quarter (July 1 - Sep 30) 2020
Registrant: TCH GROUP, LLC · Health Issues
Legislative responses to COVID-19, including establishing an emergency pharmacist Medicare provider status and S 1903 and HR 3771, advancing emergency preparedness through the One Health Act
LDA filing ↗CENCORA, INC.3rd Quarter (July 1 - Sep 30) 2021
Registrant: TCH GROUP, LLC · Health Issues
S 1362, Pharmacy and Medically Underserved Areas Enhancement Act S 1909/HR 3554- Pharmacy DIR reform Drug pricing legislation, including S 1388
LDA filing ↗CENCORA, INC.4th Quarter (Oct 1 - Dec 31) 2022
Registrant: TCH GROUP, LLC · Health Issues
Issues pertaining to pharmacists' services including S 1362, Pharmacy and Medically Underserved Areas Enhancement Act and HR 7213, Equitable Community Access to Pharmacists Services Issues relating to the pharmaceutical supply chain, including HR 2870, Essential Medicines Strategic Stockpile Act Drug pricing legislation, including S 1388
LDA filing ↗CENCORA, INC.1st Quarter (Jan 1 - Mar 31) 2024
Registrant: TCH GROUP, LLC · Health Issues
Issues pertaining to pharmacists' services including HR 1770 and S 2477, Equitable Community Access to Pharmacists Services and S.1491 Pharmacy and Medically Underserved Areas Enhancement Act Issues relating to the pharmaceutical supply chain, including HR 405, Essential Medicines Strategic Stockpile Act Drug pricing legislation, including S 113 Issues pertaining to Health sector cybersecurity
LDA filing ↗CENCORA, INC.3rd Quarter (July 1 - Sep 30) 2025
Registrant: TCH GROUP, LLC · Health Issues
Issues related to the pharmaceutical supply chain, drug shortages, drug pricing, national stockpiles, pharmacists' services, and proposals regarding bona fide service fees (2026 Physician Fee Schedule)
LDA filing ↗CENCORA, INC.1st Quarter (Jan 1 - Mar 31) 2023
Registrant: TCH GROUP, LLC · Health Issues
Issues pertaining to pharmacists' services including HR 1770, Equitable Community Access to Pharmacists Services Issues relating to the pharmaceutical supply chain, including HR 405, Essential Medicines Strategic Stockpile Act Drug pricing legislation, including S 113
LDA filing ↗CENCORA, INC.1st Quarter (Jan 1 - Mar 31) 2020
Registrant: TCH GROUP, LLC · Health Issues
Legislative responses to COVID-19, including HR 748, particularly issues relating to community pharmacies
LDA filing ↗CENCORA, INC.4th Quarter (Oct 1 - Dec 31) 2025
Registrant: TCH GROUP, LLC · Health Issues
Issues related to the pharmaceutical supply chain, drug shortages, drug pricing, national stockpiles, pharmacists' services, and proposals regarding bona fide service fees (2026 Physician Fee Schedule)
LDA filing ↗CENCORA, INC.2nd Quarter (Apr 1 - June 30) 2021
Registrant: TCH GROUP, LLC · Health Issues
HR 1319, American Rescue Plan (PL 117-2)- COVID relief including issues pertaining to vaccine distribution. HR 1868- Medicare Sequester HR 2870- Essential Medical Strategic Stockpile Act S 1901/HR 3554- Pharmacy DIR reform Monitoring drug pricing legislation
LDA filing ↗CENCORA, INC.3rd Quarter (July 1 - Sep 30) 2022
Registrant: TCH GROUP, LLC · Health Issues
Issues pertaining to pharmacists' services including S 1362, Pharmacy and Medically Underserved Areas Enhancement Act and HR 7213, Equitable Community Access to Pharmacists Services Issues relating to the pharmaceutical supply chain, including HR 2870, Essential Medicines Strategic Stockpile Act Drug pricing legislation, including S 1388
LDA filing ↗CENCORA, INC.2nd Quarter (Apr 1 - June 30) 2022
Registrant: TCH GROUP, LLC · Health Issues
Issues pertaining to pharmacists' services including S 1362, Pharmacy and Medically Underserved Areas Enhancement Act and HR 7213, Equitable Community Access to Pharmacists Services Issues relating to the pharmaceutical supply chain, stockpiling, and COVID vaccine distribution/drug shortage including HR 2870, Essential Medicines Strategic Stockpile Act Drug pricing legislation, including S 1388
LDA filing ↗CENCORA, INC.3rd Quarter (July 1 - Sep 30) 2024
Registrant: TCH GROUP, LLC · Health Issues
Issues pertaining to pharmacists' services including HR 1770 and S 2477, Equitable Community Access to Pharmacists Services and S.1491 Pharmacy and Medically Underserved Areas Enhancement Act Issues relating to the pharmaceutical supply chain, including HR 405, Essential Medicines Strategic Stockpile Act Drug pricing legislation, including S 113
LDA filing ↗CENCORA, INC.2nd Quarter (Apr 1 - June 30) 2024
Registrant: TCH GROUP, LLC · Health Issues
Issues pertaining to pharmacists' services including HR 1770 and S 2477, Equitable Community Access to Pharmacists Services and S.1491 Pharmacy and Medically Underserved Areas Enhancement Act Issues relating to the pharmaceutical supply chain, including HR 405, Essential Medicines Strategic Stockpile Act Drug pricing legislation, including S 113 Issues pertaining to Health sector cybersecurity
LDA filing ↗CENCORA, INC.2nd Quarter (Apr 1 - June 30) 2018
Registrant: TCH GROUP, LLC · Health Issues
Legislation to improve systems for identifying diversion of controlled substances and for improved reporting of information on the distribution of opioids ( S 2837 and S 2838) Legislative initiatives to modify or repeal PL 114-145, Ensuring Patient Access and Effective Drug Enforcement Act of 2016, ie S 1960 and S 2561 Issues pertaining to pharmaceutical compounding
LDA filing ↗CENCORA, INC.4th Quarter (Oct 1 - Dec 31) 2023
Registrant: TCH GROUP, LLC · Health Issues
Issues pertaining to pharmacists' services including HR 1770 and S 2477, Equitable Community Access to Pharmacists Services and S.1491 Pharmacy and Medically Underserved Areas Enhancement Act Issues relating to the pharmaceutical supply chain, including HR 405, Essential Medicines Strategic Stockpile Act Drug pricing legislation, including S 113
LDA filing ↗CENCORA, INC.1st Quarter (Jan 1 - Mar 31) 2025
Registrant: TCH GROUP, LLC · Health Issues
Issues related to the pharmaceutical supply chain, drug shortages, drug pricing, national stockpiles, and pharmacists' services
LDA filing ↗CENCORA, INC.2nd Quarter (Apr 1 - June 30) 2018
Registrant: TCH GROUP, LLC · Medicare/Medicaid
Issues relating to the payment of prescription drugs under Medicare Part B
LDA filing ↗CENCORA, INC.3rd Quarter (July 1 - Sep 30) 2023
Registrant: TCH GROUP, LLC · Health Issues
Issues pertaining to pharmacists' services including HR 1770 and S 2477, Equitable Community Access to Pharmacists Services and S.1491 Pharmacy and Medically Underserved Areas Enhancement Act Issues relating to the pharmaceutical supply chain, including HR 405, Essential Medicines Strategic Stockpile Act Drug pricing legislation, including S 113
LDA filing ↗CENCORA, INC.4th Quarter (Oct 1 - Dec 31) 2024
Registrant: TCH GROUP, LLC · Health Issues
Issues pertaining to pharmacists' services including HR 1770 and S 2477, Equitable Community Access to Pharmacists Services and S.1491 Pharmacy and Medically Underserved Areas Enhancement Act Issues relating to the pharmaceutical supply chain, including HR 405, Essential Medicines Strategic Stockpile Act Drug pricing legislation, including S 113
LDA filing ↗CENCORA, INC.4th Quarter (Oct 1 - Dec 31) 2015
Registrant: TCH GROUP, LLC · Pharmacy
S.483, Ensuring Patient Access and Effective Drug Enforcement Act of 2015
LDA filing ↗CENCORA, INC.4th Quarter (Oct 1 - Dec 31) 2017
Registrant: TCH GROUP, LLC · Taxation/Internal Revenue Code
HR 1, Tax Cuts and Jobs Act, specifically provisions relating to LIFO
LDA filing ↗CENCORA, INC.3rd Quarter (July 1 - Sep 30) 2017
Registrant: TCH GROUP, LLC · Taxation/Internal Revenue Code
Tax reform initiatives
LDA filing ↗CENCORA, INC.3rd Quarter (July 1 - Sep 30) 2019
Registrant: TCH GROUP, LLC · Health Issues
Issues concerning Medicare Part D, drug rebate reform, and Medicare Average Sales Price Methodology,
LDA filing ↗CENCORA, INC.2nd Quarter (Apr 1 - June 30) 2023
Registrant: TCH GROUP, LLC · Health Issues
Issues pertaining to pharmacists' services including HR 1770, Equitable Community Access to Pharmacists Services and S.1491 Pharmacy and Medically Underserved Areas Enhancement Act Issues relating to the pharmaceutical supply chain, including HR 405, Essential Medicines Strategic Stockpile Act, and the Senate and House (HR 2670) National Defense Authorization bills Drug pricing legislation, including S 113
LDA filing ↗